Alpine Immune Sciences logo
Alpine Immune Sciences ALPN

Quarterly report 2024-Q1
added 05-09-2024

report update icon

Alpine Immune Sciences Total Current Liabilities 2011-2026 | ALPN

Annual Total Current Liabilities Alpine Immune Sciences

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
58 M 69.8 M 41.2 M 8.68 M 8.13 M 1.9 M 6.5 M 4.42 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
69.8 M 1.9 M 24.8 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
324 M $ 20.2 -2.42 % $ 2.55 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.82 -2.95 % $ 4.47 M chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
379 M $ 166.62 0.14 % $ 8.29 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.74 -2.23 % $ 1.12 B canadaCanada
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Codexis Codexis
CDXS
23.6 M $ 0.98 -3.72 % $ 71.9 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
147 M $ 23.95 0.29 % $ 2.93 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
6.87 M $ 17.56 -1.84 % $ 843 M usaUSA
Champions Oncology Champions Oncology
CSBR
23.9 M $ 5.98 -1.48 % $ 81.7 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
16.2 M $ 17.77 -2.09 % $ 456 M usaUSA
Exelixis Exelixis
EXEL
406 M $ 40.92 -0.27 % $ 11.1 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
31.3 M $ 25.91 -3.54 % $ 694 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
35.4 M $ 2.9 -5.39 % $ 181 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Greenwich LifeSciences Greenwich LifeSciences
GLSI
1.56 M $ 27.35 -0.15 % $ 356 M usaUSA
Galecto Galecto
GLTO
5.83 M $ 29.97 -0.27 % $ 796 M danmarkDanmark
Gossamer Bio Gossamer Bio
GOSS
51.6 M $ 0.46 8.21 % $ 70.2 M usaUSA
GeoVax Labs GeoVax Labs
GOVX
3.52 M $ 1.54 -1.6 % $ 2.8 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
177 M $ 68.68 -1.68 % $ 8.23 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
831 K $ 1.0 -2.34 % $ 6.38 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
252 M $ 28.29 -2.11 % $ 1.63 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
256 M $ 3.2 -4.19 % $ 1.15 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
82.2 M $ 28.5 -2.41 % $ 1.65 B usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
4.41 M $ 6.24 -4.66 % $ 51 M usaUSA
IDEAYA Biosciences IDEAYA Biosciences
IDYA
58.8 M $ 35.14 6.34 % $ 3.11 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA